1. Home
  2. WWW vs VRDN Comparison

WWW vs VRDN Comparison

Compare WWW & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WWW
  • VRDN
  • Stock Information
  • Founded
  • WWW 1883
  • VRDN 2006
  • Country
  • WWW United States
  • VRDN United States
  • Employees
  • WWW N/A
  • VRDN N/A
  • Industry
  • WWW Shoe Manufacturing
  • VRDN Medical Specialities
  • Sector
  • WWW Consumer Discretionary
  • VRDN Health Care
  • Exchange
  • WWW Nasdaq
  • VRDN Nasdaq
  • Market Cap
  • WWW N/A
  • VRDN 1.6B
  • IPO Year
  • WWW N/A
  • VRDN N/A
  • Fundamental
  • Price
  • WWW $12.70
  • VRDN $13.50
  • Analyst Decision
  • WWW Strong Buy
  • VRDN Buy
  • Analyst Count
  • WWW 8
  • VRDN 12
  • Target Price
  • WWW $17.38
  • VRDN $36.44
  • AVG Volume (30 Days)
  • WWW 1.6M
  • VRDN 1.1M
  • Earning Date
  • WWW 05-07-2025
  • VRDN 05-07-2025
  • Dividend Yield
  • WWW 3.16%
  • VRDN N/A
  • EPS Growth
  • WWW N/A
  • VRDN N/A
  • EPS
  • WWW 0.58
  • VRDN N/A
  • Revenue
  • WWW $1,755,000,000.00
  • VRDN $302,000.00
  • Revenue This Year
  • WWW $4.50
  • VRDN N/A
  • Revenue Next Year
  • WWW $5.34
  • VRDN $20,553.29
  • P/E Ratio
  • WWW $22.25
  • VRDN N/A
  • Revenue Growth
  • WWW N/A
  • VRDN N/A
  • 52 Week Low
  • WWW $9.58
  • VRDN $9.90
  • 52 Week High
  • WWW $24.64
  • VRDN $27.20
  • Technical
  • Relative Strength Index (RSI)
  • WWW 50.91
  • VRDN 49.53
  • Support Level
  • WWW $12.15
  • VRDN $9.90
  • Resistance Level
  • WWW $13.16
  • VRDN $14.61
  • Average True Range (ATR)
  • WWW 0.92
  • VRDN 1.07
  • MACD
  • WWW 0.33
  • VRDN 0.28
  • Stochastic Oscillator
  • WWW 87.99
  • VRDN 76.43

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Share on Social Networks: